Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells

Debika Mitra, Jacklyn Whitehead, Osamu W. Yasui, Jonathan K Leach

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Perfusion culture of mesenchymal stem cells (MSCs) seeded in biomaterial scaffolds provides nutrients for cell survival, enhances extracellular matrix deposition, and increases osteogenic cell differentiation. However, there is no consensus on the appropriate perfusion duration of cellular constructs in vitro to boost their bone forming capacity in vivo. We investigated this phenomenon by culturing human MSCs in macroporous composite scaffolds in a direct perfusion bioreactor and compared their response to scaffolds in continuous dynamic culture conditions on an XYZ shaker. Cell seeding in continuous perfusion bioreactors resulted in more uniform MSC distribution than static seeding. We observed similar calcium deposition in all composite scaffolds over 21 days of bioreactor culture, regardless of pore size. Compared to scaffolds in dynamic culture, perfused scaffolds exhibited increased DNA content and expression of osteogenic markers up to 14 days in culture that plateaued thereafter. We then evaluated the effect of perfusion culture duration on bone formation when MSC-seeded scaffolds were implanted in a murine ectopic site. Human MSCs persisted in all scaffolds at 2 weeks in vivo, and we observed increased neovascularization in constructs cultured under perfusion for 7 days relative to those cultured for 1 day within each gender. At 8 weeks post-implantation, we observed greater bone volume fraction, bone mineral density, tissue ingrowth, collagen density, and osteoblastic markers in bioreactor constructs cultured for 14 days compared to those cultured for 1 or 7 days, and acellular constructs. Taken together, these data demonstrate that culturing MSCs under perfusion culture for at least 14 days in vitro improves the quantity and quality of bone formation in vivo. This study highlights the need for optimizing in vitro bioreactor culture duration of engineered constructs to achieve the desired level of bone formation.

Original languageEnglish (US)
Pages (from-to)29-39
Number of pages11
JournalBiomaterials
Volume146
DOIs
StatePublished - Nov 1 2017

Fingerprint

Bioreactors
Stem cells
Mesenchymal Stromal Cells
Osteogenesis
Scaffolds
Bone
Perfusion
Cell culture
Scaffolds (biology)
Bone and Bones
Composite materials
Biocompatible Materials
Collagen
Biomaterials
Nutrients
Pore size
Minerals
Calcium
Volume fraction
Bone Density

Keywords

  • Bioreactor
  • Bone formation
  • Composite scaffold
  • Mesenchymal stem cells
  • Osteogenic differentiation
  • Perfusion

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells. / Mitra, Debika; Whitehead, Jacklyn; Yasui, Osamu W.; Leach, Jonathan K.

In: Biomaterials, Vol. 146, 01.11.2017, p. 29-39.

Research output: Contribution to journalArticle

Mitra, Debika ; Whitehead, Jacklyn ; Yasui, Osamu W. ; Leach, Jonathan K. / Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells. In: Biomaterials. 2017 ; Vol. 146. pp. 29-39.
@article{c987ae64af02483d9b16cca448b0a25b,
title = "Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells",
abstract = "Perfusion culture of mesenchymal stem cells (MSCs) seeded in biomaterial scaffolds provides nutrients for cell survival, enhances extracellular matrix deposition, and increases osteogenic cell differentiation. However, there is no consensus on the appropriate perfusion duration of cellular constructs in vitro to boost their bone forming capacity in vivo. We investigated this phenomenon by culturing human MSCs in macroporous composite scaffolds in a direct perfusion bioreactor and compared their response to scaffolds in continuous dynamic culture conditions on an XYZ shaker. Cell seeding in continuous perfusion bioreactors resulted in more uniform MSC distribution than static seeding. We observed similar calcium deposition in all composite scaffolds over 21 days of bioreactor culture, regardless of pore size. Compared to scaffolds in dynamic culture, perfused scaffolds exhibited increased DNA content and expression of osteogenic markers up to 14 days in culture that plateaued thereafter. We then evaluated the effect of perfusion culture duration on bone formation when MSC-seeded scaffolds were implanted in a murine ectopic site. Human MSCs persisted in all scaffolds at 2 weeks in vivo, and we observed increased neovascularization in constructs cultured under perfusion for 7 days relative to those cultured for 1 day within each gender. At 8 weeks post-implantation, we observed greater bone volume fraction, bone mineral density, tissue ingrowth, collagen density, and osteoblastic markers in bioreactor constructs cultured for 14 days compared to those cultured for 1 or 7 days, and acellular constructs. Taken together, these data demonstrate that culturing MSCs under perfusion culture for at least 14 days in vitro improves the quantity and quality of bone formation in vivo. This study highlights the need for optimizing in vitro bioreactor culture duration of engineered constructs to achieve the desired level of bone formation.",
keywords = "Bioreactor, Bone formation, Composite scaffold, Mesenchymal stem cells, Osteogenic differentiation, Perfusion",
author = "Debika Mitra and Jacklyn Whitehead and Yasui, {Osamu W.} and Leach, {Jonathan K}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.biomaterials.2017.08.044",
language = "English (US)",
volume = "146",
pages = "29--39",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells

AU - Mitra, Debika

AU - Whitehead, Jacklyn

AU - Yasui, Osamu W.

AU - Leach, Jonathan K

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Perfusion culture of mesenchymal stem cells (MSCs) seeded in biomaterial scaffolds provides nutrients for cell survival, enhances extracellular matrix deposition, and increases osteogenic cell differentiation. However, there is no consensus on the appropriate perfusion duration of cellular constructs in vitro to boost their bone forming capacity in vivo. We investigated this phenomenon by culturing human MSCs in macroporous composite scaffolds in a direct perfusion bioreactor and compared their response to scaffolds in continuous dynamic culture conditions on an XYZ shaker. Cell seeding in continuous perfusion bioreactors resulted in more uniform MSC distribution than static seeding. We observed similar calcium deposition in all composite scaffolds over 21 days of bioreactor culture, regardless of pore size. Compared to scaffolds in dynamic culture, perfused scaffolds exhibited increased DNA content and expression of osteogenic markers up to 14 days in culture that plateaued thereafter. We then evaluated the effect of perfusion culture duration on bone formation when MSC-seeded scaffolds were implanted in a murine ectopic site. Human MSCs persisted in all scaffolds at 2 weeks in vivo, and we observed increased neovascularization in constructs cultured under perfusion for 7 days relative to those cultured for 1 day within each gender. At 8 weeks post-implantation, we observed greater bone volume fraction, bone mineral density, tissue ingrowth, collagen density, and osteoblastic markers in bioreactor constructs cultured for 14 days compared to those cultured for 1 or 7 days, and acellular constructs. Taken together, these data demonstrate that culturing MSCs under perfusion culture for at least 14 days in vitro improves the quantity and quality of bone formation in vivo. This study highlights the need for optimizing in vitro bioreactor culture duration of engineered constructs to achieve the desired level of bone formation.

AB - Perfusion culture of mesenchymal stem cells (MSCs) seeded in biomaterial scaffolds provides nutrients for cell survival, enhances extracellular matrix deposition, and increases osteogenic cell differentiation. However, there is no consensus on the appropriate perfusion duration of cellular constructs in vitro to boost their bone forming capacity in vivo. We investigated this phenomenon by culturing human MSCs in macroporous composite scaffolds in a direct perfusion bioreactor and compared their response to scaffolds in continuous dynamic culture conditions on an XYZ shaker. Cell seeding in continuous perfusion bioreactors resulted in more uniform MSC distribution than static seeding. We observed similar calcium deposition in all composite scaffolds over 21 days of bioreactor culture, regardless of pore size. Compared to scaffolds in dynamic culture, perfused scaffolds exhibited increased DNA content and expression of osteogenic markers up to 14 days in culture that plateaued thereafter. We then evaluated the effect of perfusion culture duration on bone formation when MSC-seeded scaffolds were implanted in a murine ectopic site. Human MSCs persisted in all scaffolds at 2 weeks in vivo, and we observed increased neovascularization in constructs cultured under perfusion for 7 days relative to those cultured for 1 day within each gender. At 8 weeks post-implantation, we observed greater bone volume fraction, bone mineral density, tissue ingrowth, collagen density, and osteoblastic markers in bioreactor constructs cultured for 14 days compared to those cultured for 1 or 7 days, and acellular constructs. Taken together, these data demonstrate that culturing MSCs under perfusion culture for at least 14 days in vitro improves the quantity and quality of bone formation in vivo. This study highlights the need for optimizing in vitro bioreactor culture duration of engineered constructs to achieve the desired level of bone formation.

KW - Bioreactor

KW - Bone formation

KW - Composite scaffold

KW - Mesenchymal stem cells

KW - Osteogenic differentiation

KW - Perfusion

UR - http://www.scopus.com/inward/record.url?scp=85028933398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028933398&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2017.08.044

DO - 10.1016/j.biomaterials.2017.08.044

M3 - Article

VL - 146

SP - 29

EP - 39

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -